Karoo Health closes USD 16.2M Series A financing round
Karoo Health announced the closing of a $16.2 million Series A financing round co-led by 7wire Ventures and Allumia Ventures, with participation from First Trust Capital Partners, LLC, SpringRock Ventures, Hyde Park Angels (HPA), and other marquee investors.
As part of the financing, Lee Shapiro, Managing Partner at 7wire Ventures, and Jeff Stolte, Managing Partner at Allumia Ventures, will join Karoo’s Board of Directors.
Karoo is building an operating system for cardiovascular care, a technology platform designed to connect payers, providers, and patients through a unified data and workflow layer that supports earlier risk detection, care coordination, and overall improved cardiovascular disease outcomes.
The company’s mission is to free people from the pain of cardiovascular disease at scale through earlier detection, improved coordination, and data-driven care delivery.
“We’re at a seminal moment in our country’s fight against cardiovascular disease,” said Karoo Health CEO and Cofounder Ian Koons. “We intend to use this capital to take another major step toward becoming the solution that enables every American to access earlier, more coordinated, and more effective cardiovascular care.”
Cardiovascular disease remains the leading driver of healthcare costs in the United States, and care delivery remains fractured across clinical systems, claims data, pharmacy records, and care teams. This fragmentation contributes to delayed intervention, inconsistent chronic disease management, and avoidable hospital utilization, procedures, and testing.
“The challenge in cardiovascular care today isn’t a shortage of innovation but a system too fragmented to deliver it consistently,” said Lee Shapiro, Managing Partner of 7wire Ventures. “That fragmentation is precisely the kind of problem the right technology can solve. Karoo is creating the connective layer that lets care teams act on a complete picture of each patient, and its deployments are already producing meaningful reductions in avoidable utilization and cost. We are proud to co-lead this round.”
Today, Karoo supports a network of more than 600 cardiology providers across 11 states, operates programs with leading national and regional health plans and is launching with others later this year.
In deployed programs, independent analyses reported reductions of more than 40% in emergency department visits and inpatient admissions, and early results show a greater than 10% reduction in total cost of care throughout attributed populations.
“We’ve been waiting for a company with the technology, clinical vision, and leadership team capable of fundamentally changing how cardiac care is delivered. We believe Karoo Health is that company, and we’re proud to support their mission to improve outcomes for patients at scale while helping build a more proactive, connected, and effective model for cardiovascular care,” said Jeff Stolte, Managing Partner at Allumia Ventures.
Karoo will use proceeds from the financing to further develop its AI-native cardiovascular platform, including continued development of predictive models, clinical signal detection capabilities, and care coordination infrastructure. The company also plans to expand its engineering and clinical teams and continue scaling deployments with payer and provider partners.
MB Bureau
